Suraksha Diagnostic Ltd's Q3FY25 Quarter Results
- 09 Feb 2025
Result Summary
- Suraksha Diagnostic Ltd reported a 11.7% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 14.1%.
- Its expenses for the quarter were down by 4.4% QoQ and up 12.1% YoY.
- The net profit decreased 41.1% QoQ and increased 32.0% YoY.
- The earnings per share (EPS) of Suraksha Diagnostic Ltd stood at 1.2 during Q3FY25.
Financial Statments for Q3FY25
| (₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 60.11 | 68.07 | 52.67 | -11.7% | 14.1% |
Total Expenses | 52.07 | 54.44 | 46.46 | -4.4% | 12.1% |
Profit Before Tax | 8.05 | 13.63 | 6.22 | -40.9% | 29.4% |
Tax | 2.06 | 3.48 | 1.68 | -40.8% | 22.6% |
Profit After Tax | 5.98 | 10.15 | 4.53 | -41.1% | 32.0% |
Earnings Per Share | 1.20 | 1.90 | 0.90 | -36.8% | 33.3% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Suraksha Diagnostic Ltd is a company operating in the healthcare services sector, specializing in diagnostic services such as pathology and radiology. The company is known for providing a wide range of diagnostic tests and healthcare services to meet the needs of patients seeking reliable medical test results. Although detailed information about recent major developments is not available, the diagnostic industry generally sees steady demand due to the essential nature of its services. Suraksha Diagnostic Ltd is positioned in an industry that plays a crucial role in healthcare by offering essential diagnostic information to both healthcare providers and patients.
Revenue
In the third quarter of the fiscal year 2025 (Q3FY25), Suraksha Diagnostic Ltd reported a total income of ₹60.11 crores. This represents a decline of 11.7% compared to the previous quarter (Q2FY25), where the total income was ₹68.07 crores. However, on a year-over-year basis, there was a 14.1% increase from Q3FY24, when the total income was ₹52.67 crores. This YoY growth indicates an overall increase in revenue compared to the same period in the previous year, despite the QoQ decrease.
Profitability
Suraksha Diagnostic Ltd's profitability metrics for Q3FY25 show a profit before tax (PBT) of ₹8.05 crores, which is a 40.9% decline from the previous quarter's PBT of ₹13.63 crores. However, compared to the same quarter last year (Q3FY24), there is a 29.4% increase, as the PBT was ₹6.22 crores in that period. The profit after tax (PAT) for Q3FY25 was ₹5.98 crores, showing a 41.1% decrease from Q2FY25's PAT of ₹10.15 crores but a 32.0% increase from Q3FY24's PAT of ₹4.53 crores. The earnings per share (EPS) for Q3FY25 was ₹1.20, which decreased by 36.8% from the previous quarter, while it increased by 33.3% compared to the same quarter last year.
Operating Metrics
Total expenses for Suraksha Diagnostic Ltd in Q3FY25 amounted to ₹52.07 crores, reflecting a 4.4% decrease from the previous quarter's expenses of ₹54.44 crores. Year-over-year, total expenses increased by 12.1% from ₹46.46 crores in Q3FY24. The tax expense for Q3FY25 was ₹2.06 crores, which is a 40.8% decrease from the previous quarter's tax expense of ₹3.48 crores, and a 22.6% increase compared to the same quarter last year, where the tax expense was ₹1.68 crores. These metrics highlight the financial performance and operational cost dynamics of the company during the reported quarter.
